• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物溶解度、载药量和聚合物分子量对泊洛沙姆片药物释放的影响。

Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.

作者信息

Kim C J

机构信息

School of Pharmacy, Temple University, Philadelphia, Pennsylvania 19140, USA.

出版信息

Drug Dev Ind Pharm. 1998 Jul;24(7):645-51. doi: 10.3109/03639049809082366.

DOI:10.3109/03639049809082366
PMID:9876509
Abstract

This study investigated the effects of polymer molecular weight, drug solubility, addition of a water-soluble excipient, and drug loading on zero-order release kinetics and elucidated the release mechanism of a drug from directly compressed tablets. Directly compressed tablets consisting of polyethylene oxides (PEO) (MW = 0.9, 2.0 and 4.0 x 10(6)) and drugs (solubility ranging from 290 to 25,000 mg/l) were formulated with or without a water-soluble excipient (lactose). For PEO tablets (MW = 0.9 x 10(6)), drug release is primarily swelling/erosion controlled for drugs for which solubility is below 1%, resulting in zero-order release kinetics. For PEO tablets (MW = 4.0 x 10(6)), drug release is controlled at a zero-order rate by the dissolution rate of the drug at high loading (39%). At low loading (20%), drug diffusion through the swollen gel layer becomes the governing release mechanism. For a highly water-soluble drug (e.g., diclofenac Na), drug diffusion is the controlling mechanism regardless of the molecular weight of the PEOs. Zero-order release kinetics can be achieved with PEO tablets (MW = 0.9 x 10(6)) for drugs for which solubility is below 1%. PEO tablets (MW = 2.0 x 10(6)) provided zero-order release for poorly water-soluble drugs (below 0.2%) at 39% drug loading. It is possible to attain zero-order release kinetics with PEO tablets (MW = 4.0 x 10(6)) using a drug which has a solubility of less than 0.1%.

摘要

本研究考察了聚合物分子量、药物溶解度、水溶性辅料的添加以及载药量对零级释放动力学的影响,并阐明了药物从直接压片中的释放机制。由聚环氧乙烷(PEO)(分子量分别为0.9×10⁶、2.0×10⁶和4.0×10⁶)和药物(溶解度范围为290至25000mg/L)组成的直接压片,在有或没有水溶性辅料(乳糖)的情况下进行配方。对于PEO片(分子量 = 0.9×10⁶),对于溶解度低于1%的药物,药物释放主要受溶胀/侵蚀控制,导致零级释放动力学。对于PEO片(分子量 = 4.0×10⁶),在高载药量(39%)下,药物释放由药物的溶解速率以零级速率控制。在低载药量(20%)时,药物通过溶胀凝胶层的扩散成为主要的释放机制。对于高水溶性药物(如双氯芬酸钠),无论PEO的分子量如何,药物扩散都是控制机制。对于溶解度低于1%的药物,PEO片(分子量 = 0.9×10⁶)可实现零级释放动力学。PEO片(分子量 = 2.0×10⁶)在39%载药量下为低水溶性药物(低于0.2%)提供零级释放。使用溶解度小于0.1%的药物,PEO片(分子量 = 4.0×10⁶)有可能实现零级释放动力学。

相似文献

1
Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.药物溶解度、载药量和聚合物分子量对泊洛沙姆片药物释放的影响。
Drug Dev Ind Pharm. 1998 Jul;24(7):645-51. doi: 10.3109/03639049809082366.
2
Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.通过在聚环氧乙烷(PEO)/聚乙二醇(PEG)基质片剂中利用反聚合物实现大量高水溶性盐酸地尔硫䓬的缓释。
Eur J Pharm Biopharm. 2008 Oct;70(2):556-62. doi: 10.1016/j.ejpb.2008.05.032. Epub 2008 Jun 19.
3
Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.盐酸地尔硫䓬三层胃滞留型给药系统的制剂、体外评价及变量研究。
Drug Dev Ind Pharm. 2014 Mar;40(3):380-9. doi: 10.3109/03639045.2012.763138. Epub 2013 Feb 1.
4
Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.双层和三层片剂药物传输系统,用于口服释放可溶性和难溶性药物的持续释放。
Drug Dev Ind Pharm. 2010 Aug;36(8):903-16. doi: 10.3109/03639040903585119.
5
Water soluble drug delivery systems based on a non-biological bioadhesive polymeric system.基于非生物生物粘附聚合物体系的水溶性药物递送系统。
Farmaco. 1994 Dec;49(12):809-18.
6
Drug release from compressed hydrophilic POLYOX-WSR tablets.亲水性聚氧乙烯(POLYOX-WSR)压制片的药物释放
J Pharm Sci. 1995 Mar;84(3):303-6. doi: 10.1002/jps.2600840308.
7
Sandwiched osmotic tablet core for nifedipine controlled delivery.用于硝苯地平控释的夹层渗透片芯
Biomed Mater Eng. 1999;9(5-6):297-310.
8
Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights.通过高膨胀性和溶解性聚合物基质实现药物控释的数学建模与体外研究:高分子量聚环氧乙烷
J Control Release. 2005 Feb 16;102(3):569-81. doi: 10.1016/j.jconrel.2004.11.002.
9
In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.应用不同相对分子质量的聚氧化乙烯(PEO)作为阻滞剂的高水溶性药物控释骨架片的体外和体内评价。
Drug Dev Ind Pharm. 2018 Apr;44(4):544-552. doi: 10.1080/03639045.2017.1405429. Epub 2017 Nov 21.
10
Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.药物溶解度对 HPMC 基质制剂中水溶性和难溶性药物释放动力学的影响。
Acta Pharm. 2009 Sep;59(3):313-23. doi: 10.2478/v10007-009-0025-8.

引用本文的文献

1
Impact of drug loading on release from levonorgestrel intrauterine systems.药物载量对左炔诺孕酮宫内节育系统释放的影响。
Int J Pharm. 2023 Jan 25;631:122532. doi: 10.1016/j.ijpharm.2022.122532. Epub 2022 Dec 21.
2
Effect of Manufacturing Process on the Retention of Abuse-Deterrent Properties of PEO-Matrix Tablets.制造工艺对 PEO 基质片滥用防御性能保留的影响。
AAPS PharmSciTech. 2021 Dec 27;23(1):38. doi: 10.1208/s12249-021-02169-6.
3
The Properties of HPMC:PEO Extended Release Hydrophilic Matrices and their Response to Ionic Environments.
羟丙甲纤维素:聚氧化乙烯缓释亲水基质的性质及其对离子环境的响应
Pharm Res. 2017 May;34(5):941-956. doi: 10.1007/s11095-016-2031-0. Epub 2016 Sep 15.
4
Design and development of polyethylene oxide based matrix tablets for verapamil hydrochloride.盐酸维拉帕米聚环氧乙烷基骨架片的设计与开发
Indian J Pharm Sci. 2013 Mar;75(2):185-90.
5
An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders.考察聚环氧乙烷老化粉末基质中盐酸地尔硫䓬释放的稳定性。
AAPS PharmSciTech. 2013 Sep;14(3):1190-8. doi: 10.1208/s12249-013-0013-7. Epub 2013 Jul 31.
6
Challenges and opportunities in achieving bioequivalence for fixed-dose combination products.实现固定剂量复方制剂生物等效性的挑战与机遇。
AAPS J. 2012 Sep;14(3):646-55. doi: 10.1208/s12248-012-9378-x. Epub 2012 Jun 9.
7
A new application of lipid nanoemulsions as coating agent, providing zero-order hydrophilic drug release from tablets.脂质纳米乳剂作为包衣剂的新应用,可实现片剂中亲水性药物的零级释放。
J Drug Deliv. 2012;2012:271319. doi: 10.1155/2012/271319. Epub 2012 Jan 9.
8
Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test.基于自微乳混合物的新型胃滞留型他克莫司缓释片:体外评价和体内生物利用度试验。
Acta Pharmacol Sin. 2011 Oct;32(10):1294-302. doi: 10.1038/aps.2011.90. Epub 2011 Sep 19.
9
Controlled release systems containing solid dispersions: strategies and mechanisms.载药固体分散体的控释系统:策略与机制。
Pharm Res. 2011 Oct;28(10):2353-78. doi: 10.1007/s11095-011-0449-y. Epub 2011 May 7.
10
Preparation and in-vivo pharmacokinetic study of a novel extended release compression coated tablets of fenoterol hydrobromide.新型氢溴酸非诺特罗缓释包衣压片的制备及体内药代动力学研究
AAPS PharmSciTech. 2008;9(3):1016-24. doi: 10.1208/s12249-008-9135-8. Epub 2008 Sep 3.